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PROGRESS REPORT  
Non-heme metallo oxygenases represent more than 80% of all known dioxygenases and 
a large number of monooxygenases, and thus a definition of the molecular basis of their 
catalytic action is highly relevant to many key biological processes. The broad 
objective of our program is to continue our analysis of the involvement of non-heme iron 
in the catalytic pathway of the bacterial dioxygenase, protocatechuate-3,4-dioxygenase 
(PCD), and to carry out comparative studies with the mamalian non-heme iron 
monooxygenase, liver phenylalanine hydroxylase (PAH), the mamalian coppper monooxygenase, 
dopamine-B-monooxygenase (DBM), and the bacterial non-heme iron monooxygenase, P. 
oleovorans epoxidase/hydroxylase (POEH). 
The following paragraphs summarize our progress during this past year of our 
program. 
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Aromatic Dioxygenases, Transferrin and Model Complexes  
Substrates and Inhibitors: 	During this past year, this part of our dioxygenase 
program focused almost entirely on working out the biochemical conditions necessary for 
building up and trapping the "ES0 2" transient species along the reaction pathway of 
the slow substrate, 3,4-dihydroxyphenylpropionate. We considered this of utmost 
priority, since successful EXAFS of this species would represent, to our knowledge, the 
first time this technique has ever been applied to a fully competent transient of a 
reaction pathway (as opposed to an inhibitor complex or a substrate complex lacking a 
reactant, such as ES for PCD). Together with our ongoing work on EI, ES, and E 
transition state analogs, results with ES0 2 would provide highly signiicant insight 
into the ligation changes at Fe during individual steps along the catalytic pathway. 
A protocol was developed to monitor ES0 2 formation and decay under varying 
conditions of solvent and concentrations of reactants. The exceedingly high amounts of 
enzyme required for EXAFS is always a problem which must be overcome, but in this case 
the problem was confounded by the fact that a buildup of ESO 2 of 2-3 mM would be 
required for accurate EXAFS analysis, which is far in excess of the total solubility of 
oxygen in water at room temperature. After many trials, procedures were worked out to 
buildup ES0 2 under hyperbaric oxygen conditions (3-4 atm.) at 4 C, and to rapidly 
trap this species by freezing at -80
o 
 C. Kinetic methods were worked out to measure 
the germane rate constants and monitor formation and decomposition of the transients, in 
order to assure agreement with values previously determined by steady state and stopped 
flow analyses. Laborious, large-scale isolations were carried out to provide sufficient 
enzyme for these studies and for preparation of the sample which was actually subjected 
to EXAFS analysis in our December 1986 Brookhaven run (see below). 
Other experiments in this phase of the program included preparation of crystals 
of PCD for solid state EXAFS measurements as a prelude to experiments were S and/or I 
will be diffused directly into such crystals. Also, careful reconstitution experiments 
on transferrin species were carried out in order to resolve some inconsistencies in our 
initial EXAFS reults with this protein. 
EXAFS: The intensity and quality of the NSLS beam is markedly improved and has 
permitted us to collect XAFS on a number of samples. 
As discussed above, "ES0, 7" was trapped in an EXAFS cell at cryogenic 
temperature and its optical spectrum measured immediately prior to and following the 
EXAFS data collection by means of a specially constructed double beam fiber optic 
spectrometer. The spectra showed some alteration due to irradiation, which is plausibly 
assigned to ozinide formation in the 0 2-rich sample. Upon thawing and further 
reaction, the characteristic ES spectrum was observed. This confirms that, upon thawing, 
the expected turnover of "ESO 2" indeed occurred, thus depeleting oxygen and trapping 
the PCD as ES due to the prsence of excess substrate. Since the solution was frozen, 
care was taken to move the sample slightly during data collection to reduce or remove 
Bragg peak scattering. Preliminary analyses showed the following: (1) loss of chelation 
by substrate or product, (2) a six-coordinate iron, similar to ES but in contrast to 
native PCD, (3) strong disorder of the first-shell relative to E or ES, (4) retention of 
histidyl ligation. First-shell analyses on E, ES, EI, and complexes with transition state 
analog is complete. The iron in native PCD and its complexes with 
3-chloro-hydroxybenzoate (I) or TSA (TSA = 2-hydoxyisoniciotinic acid N-oxide) is five 
coordinate; in contrast, the iron in ES (S = protocatechuate, 5-bromoprotocatechuate, or 
dihydroxyphenylpropionate) is six coordinate. Average first-shell distances in E, ES, 
and EI are about 2.00 A, while E.TSA complexes possess average distances of 2.05 A. 
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Excepting the anomalous EI complex, all species show two histidyl ligands at the active 
site. 
A collaboration with S. Mangani and I. Bertini (Italy) has been initiated on 
EXAFS studies of transferrin. Our interest is to understand in transferrin and PCD 
structural differences at the iron-containing site of the proteins, which contain very 
similar ligands at this site. We see clear differences in the first and third (His) 
shell. 
In a preliminary investigation of the utility of EXAFS to examine crystalline 
enzyme complexes, we have obtained data on thermolysin and its complexes with the 
inhibitors, HSCH2-CH(CH2Bz)CO-Ala-Gly-NH2 and HONH-Bzm-Ala-Gly-OH. The data are of 
excellent quality and exhibit changes at the Zn due to binding. Upon completion of the 
analysis, comparsion will be made between EXAFS and X-ray crystallographic results. 
Metallo-Monooxygenases: Phenylalanine Hydroxylase and Dopamine-B-Monooxygenase  
As mentioned in last year's report, isolation of PAH on the scale required for 
EXAFS, as well as stability of the protein itself and of the Fe ligation environment, 
represent major quetsions which must be resolved if EXAFS is to be fruitfully applied to 
this protein. Many large scale isolations were carried out this past year using several 
variations of both the Kaufman and Shiman literature procedure. (We recently calculated 
that the total PAH isolated this past year exceeds the total of a decade of literature 
reports from the Kaufman lab!) Since for EXAFS purposes it is critical to remove any 
contaminating ferritin, we now utilize FPLC as a final purification step, and we 
routinely examine isolated PAH by electrophoresis. 
Serious problems have been encountered in preparing PAH samples suitable for 
EXAFS. Typically, combined preps totalling about 50 - 60 mg of PAH are accumulated and 
then concentrated to volumes below 500 microliters in order to produce a final solution 
sufficiently concentrated for meaningful EXAFS (ca. 2 mM in Fe). With some samples of 
PAH this has caused cloudiness and precipitate formation. Of even greater concern is 
that while we take care to measure specific activity and to determine Fe concentration 
colorimetrically after purification and again after EXAFS, our December 1986 Brookhaven 
data indicated that only a fraction of the expected Fe was actually present in the 
sample. This is highly puzzling; it may indicate leakage of Fe during ultrafiltration, 
something totally inconsistent with statements in the literature. Moreover, there is 
possiblity that PAH becomes unstable at such extremely high concentrations. We are 
currently completing the prepration of new PAH and also attempting to reconstitute 
earlier preps which had previously been highly concentrated by ultrafiltration. We are 
scheduled to run these samples at Brookhaven on 19 January, 1987. 
Preliminary EXAFS analysis on a 0.7mM (in iron) sample of PAH showed a first 
shell dominated by nitrogenous ligands with an average distance of 2.04 A. 
As mentioned in our last report, very good progress has been made in preparation 
and characterization of modified phenylalanines and pterins. Alternate catalytic 
competencies for PAH will be investigated using our novel substrate analogs, vinyl-Phe 
and pMeS-Phe, as soon as our January EXAFS run is complete. A prototype of another novel 
class of compounds has been prepared as a potential mechanism-based inhibitor for PAH. 
The p-pyridine analog of Phe has been prepared and characterized, and we plan to 
synthesize the m- isomer as well. If PAH is capable of oxygenating such compounds to the 
corresponding pyridine N-oxides, these should be potent ligands for the Fe and may be 
excellent inhibitors. Moreover, the N-oxides are very useful EXAFS probes in 
investigating the question of whether the Fe is actually participating in substrate 
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oxygenation. Once again, these studies will occupy our attention during the coming year. 
We now have in hand a vastly more efficient isolation method for 
dopamine-b-monooxygenase, which starts with isolation and purification of chromaffin 
cells. We calculate that one month of isolation work will provide more than enough DBM 
for EXAFS. We plan to run E and EI samples with DBM once beam time becomes available to 
us after the 5-6 month Brookhaven shutdown which commences in March, 1987. 
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